AI assistant
Sending…
Ocugen, Inc. — Director's Dealing 2014
Dec 3, 2014
32915_dirs_2014-12-02_f7029c35-f1bc-4da9-be0c-99fdb965ba0c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: HISTOGENICS CORP (HSGX)
CIK: 0001372299
Period of Report: 2014-12-02
Reporting Person: Baltzell Joshua J (Director)
More from Ocugen, Inc.
Board/Management Information
2026
Jun 3
Board/Management Information
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 5
Capital/Financing Update
2026
May 4
Annual Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 24
Capital/Financing Update
2026
Mar 20
Annual Report
2026
Mar 4